Karl Baisch GmbH has been acquired by Friedrich Ziegler GmbH
Friedrich Ziegler GmbH, a manufacturer of furniture for a variety of industries such as medical rooms, kitchens and stores, has acquired the intangible assets of Karl Baisch GmbH within an asset deal. Financial details of this transaction have not been disclosed.
Karl Baisch GmbH is the leading manufacturer of dental furniture in Europe's German-speaking countries. The company has experienced financial difficulties for a number of years due to internal structural problems and the changing market environment. Despite the implementation of various measures to stabilise the business, the company has been unable to achieve a sustainable turnaround and was forced to file for insolvency.
Dr. Hendrik Hefermehl from Stuttgart has been appointed as the insolvency administrator.
Oaklins' team in Germany was commissioned exclusively by the insolvency administrator to provide assistance on the transfer of the company and its assets.
![](/api/deal-hero-image/22995/deal-hero-image.jpg)
![](/api/deal-party-images/22995/deal-parties.png)
Talk to the deal team
Related deals
Leika Medical Equipments Ltd. has been acquired by Angus Capital
The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.
Learn morePhen’X Technologies has sold a majority stake to Ciclad
The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.
Learn moreMedis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments
Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).
Learn more